Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: 18F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma

Fig. 2

18F-fluoride-PET-CT and MAR (patient BBR01). a 18F-fluoride-PET before and after treatment is shown. It is illustrated that there is a large variety in 18F-uptake within the patient (range 7.34 to 11.34). After treatment, an increase in 18F-uptake in almost all lesions is seen, again with pronounced intra-individual heterogeneity (range 12.50 to 17.49). b CT and 18F-fluoride-PET of the iliac crest are shown. It is illustrated that the increase in 18F-uptake (11.34 to 13.09) after treatment at the site of the biopsy (red arrow) correlates with a decrease in extramedullary plasmacytoma and increase in osteosclerosis. c The biopsy was taken of the right iliac crest (red arrow in panel a and b). The increase in 18F-uptake (11.34 to 13.09) at this site is reflected by an increase in MAR (1.04 to 1.26). The double layers are pointed by white arrows

Back to article page